TR-012001

· SNLD, Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TR-012001, covering 2024-06-06 to 2024-06-06. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Clinical Study of TR-012001 in Japanese Patients With Parkinson's Disease [Phase 2]